Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gender Differences in Nonalcoholic Fatty Liver Disease
Aabha Nagral, Manisha Bangar, Sherna Menezes, et al.
Euroasian Journal of Hepato-Gastroenterology (2022) Vol. 12, Iss. S1, pp. S19-S25
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Global prevalence of nonalcoholic fatty liver disease: an updated meta-analysis on 78 million population over 38 countries
Ehsan Amini‐Salehi, Negin Letafatkar, Naeim Norouzi, et al.
Archives of Medical Research (2024) Vol. 55, Iss. 6, pp. 103043-103043
Closed Access | Times Cited: 37
Inequities in primary liver cancer in Europe: The state of play
Loreta A. Kondili, Jeffrey V. Lazarus, Peter Jepsen, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 4, pp. 645-660
Open Access | Times Cited: 21
Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease
Alessandro Cherubini, Sara Della Torre, Serena Pelusi, et al.
Trends in Molecular Medicine (2024)
Closed Access | Times Cited: 21
Gender Differences in Insulin Resistance: New Knowledge and Perspectives
Tiziana Ciarambino, Pietro Crispino, Gloria Guarisco, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 10, pp. 7845-7861
Open Access | Times Cited: 42
From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences
Ahmed Samy, Mohamed A. Kandeil, Dina Sabry, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30387-e30387
Open Access | Times Cited: 15
Fatty Liver Index (FLI) is the best score to predict MASLD with 50% lower cut-off value in women than in men
Lucilla Crudele, Carlo De Matteis, Fabio Novielli, et al.
Biology of Sex Differences (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Psychosocial risks in Metabolic dysfunction-associated steatotic liver disease
Hanne Åström, Christine Takami Lageborn, Hannes Hagström
Expert Review of Gastroenterology & Hepatology (2025)
Closed Access | Times Cited: 1
MASLD: Prevalence, Mechanisms, and Sex-Based Therapies in Postmenopausal Women
Ilaria Milani, Marianna Chinucci, Frida Leonetti, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 855-855
Open Access | Times Cited: 1
NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay
Simona Cernea
Life (2024) Vol. 14, Iss. 2, pp. 272-272
Open Access | Times Cited: 8
Mid-term Effects of Bariatric Surgery on Metabolic Dysfunction-Associated Fatty Liver Disease Remission and Predictive Factors: A Prospective Study with a Focus on Non-invasive Diagnosis
Èlia Navarro‐Masip, Núria Mestres Petit, Marta Zorzano-Martínez, et al.
Obesity Surgery (2024) Vol. 34, Iss. 3, pp. 841-849
Closed Access | Times Cited: 7
Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives
Janitha M. Unagolla, Subarna Das, Riley Flanagan, et al.
International Journal of Pharmaceutics (2024) Vol. 660, pp. 124381-124381
Closed Access | Times Cited: 7
Trehalose promotes atherosclerosis regression in female mice
Sabrina Robichaud, Valérie Rochon, Christina Emerton, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 6
Uncoupling hepatic insulin resistance – hepatic inflammation to improve insulin sensitivity and to prevent impaired metabolism-associated fatty liver disease in type 2 diabetes
S. Niranjan, Brett E. Phillips, Nick Giannoukakis
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 15
Effect of Intermittent Fasting on Lipid Profile, Anthropometric and Hepatic Markers in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review
María Fernanda Castillo, Daniela Salgado-Canales, Marco Arrese, et al.
Current Vascular Pharmacology (2024) Vol. 22, Iss. 3, pp. 187-202
Closed Access | Times Cited: 5
Exploring Biomarkers in Nonalcoholic Fatty Liver Disease Among Individuals With Type 2 Diabetes Mellitus
Fariba Ahmadizar, Zobair M. Younossi
Journal of Clinical Gastroenterology (2024)
Closed Access | Times Cited: 5
Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: A Bidirectional Association Based on Endothelial Dysfunction
Nikolaos Ktenopoulos, Μarios Sagris, Maria Gerogianni, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10595-10595
Open Access | Times Cited: 4
Developmental Programming: Sex-specific Effects of Prenatal Exposure to a Real-Life Mixture of Environmental Chemicals on Liver Function and Transcriptome in Sheep.
Soundara Viveka Thangaraj, Michelle Bellingham, Richard G. Lea, et al.
Environmental Pollution (2025) Vol. 367, pp. 125630-125630
Closed Access
Prevalence and association of metabolism-associated steatotic liver disease across age groups and gender
Salvatore Corrao, Salvatore Scibetta, Serena Scardina, et al.
Nutrition Metabolism and Cardiovascular Diseases (2025), pp. 103926-103926
Closed Access
Comparative diagnostic value of novel and traditional anthropometric indices in FibroScan-diagnosed NAFLD among Turkish adults
Murat Keskın, Nizameddin Koca
Journal of Medicine and Palliative Care (2025) Vol. 6, Iss. 2, pp. 78-84
Closed Access
Early stage of metabolic dysfunction associated steatotic liver disease disrupts circadian rhythm and induces neuroinflammation in rats
Paul‐Henri Graindorge, Justine Paoli, Burak Oğulcan Yıldırım, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Fatty Liver and Hyperuricemia in Workers: Combined Effects on Metabolic Dysfunction and the Role of Lifestyle Factors
Jui‐Hua Huang, Ren-Hau Li, Hon‐Ke Sia, et al.
Metabolites (2025) Vol. 15, Iss. 5, pp. 318-318
Open Access
Precision Non-Alcoholic Fatty Liver Disease (NAFLD) Diagnosis: Leveraging Ensemble Machine Learning and Gender Insights for Cost-Effective Detection
Azadeh Alizargar, Yang-Lang Chang, Mohammad Alkhaleefah, et al.
Bioengineering (2024) Vol. 11, Iss. 6, pp. 600-600
Open Access | Times Cited: 3
Regulation of Mitochondrial and Peroxisomal Metabolism in Female Obesity and Type 2 Diabetes
Damián A. Antelo-Cea, Laura Martínez-Rojas, Izan Cabrerizo-Ibáñez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11237-11237
Open Access | Times Cited: 2
Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?
Julia A. Golubeva, А.Ф. Шептулина, A. Yu. Elkina, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2465-2465
Open Access | Times Cited: 5
The Pivotal Role of the Membrane-Bound O-Acyltransferase Domain Containing 7 in Non-Alcoholic Fatty Liver Disease
Preethi Chandrasekaran, Ralf Weiskirchen
Livers (2023) Vol. 4, Iss. 1, pp. 1-14
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top